Trends in stereotactic body radiation therapy for stage I small cell lung cancer

详细信息    查看全文

• 作者：John M. Stahl^a ; Christopher D. Corso^a ; Vivek Verma^b ; Henry S. Park^a ; Sameer K. Nath^a ; Zain A. Husain^a ; Charles B. Simone II^c ; Anthony W. Kim^d ; Roy H. Decker^a ; ^{roy.decker@yale.edu}
• 关键词：SBRT ; SCLC ; Stage I ; NCDB ; Medically inoperable
• 刊名：Lung Cancer
• 出版年：2017
• 出版时间：January 2017
• 年：2017
• 卷：103
• 期：Complete
• 页码：11-16
• 全文大小：988 K
• 卷排序：103

文摘

SBRT utilization for stage I SCLC has increased over the last decade. This has occurred despite a lack of national guidelines or data supporting its use. Radiation dose prescription trends mirror that of SBRT in NSCLC. The role of SBRT for inoperable cT1-2 N0 SCLC requires further research.